Shares of ENGN stock opened at $5.96 on Monday. enGene has a fifty-two week low of $4.42 and a fifty-two week high of $18.40. The stock’s 50-day moving average is $8.13 and its two-hundred day ...

Analyst Price Forecast Suggests 395.71% Upside As of December 23, 2024, the average one-year price target for enGene Holdings is $28.90/share. The forecasts range from a low of $16.16 to a high of ...

On Monday, H.C. Wainwright began coverage on Engene Holdings Inc. (NASDAQ:ENGN) with a Buy rating and a price target of $25.00. The firm's analyst highlighted the potential of enGene's gene ...

H.C. Wainwright analyst Andres Maldonado initiated coverage of enGene (ENGN) with a Buy rating and $25 price target The firm says the The non-muscle invasive bladder cancer treatment landscape is ...

enGene Trading Down 2.2 % Shares of NASDAQ ENGN opened at $5.83 on Monday. The company has a current ratio of 19.52, a quick ratio of 19.52 and a debt-to-equity ratio of 0.09. enGene Holdings Inc ...

Easily identify outperforming stocks and invest smarter with Top Smart Score Stocks Engene Holdings Inc. faces significant business risks due to its limited experience in conducting later-stage ...

enGene Holdings Inc. (NASDAQ:ENGN), a $304 million market cap biotech firm whose shares have declined 35% year-to-date, has entered into a sales agreement with Jefferies LLC, enabling the company to ...

enGene Holdings Inc. (ENGN) could be a solid addition to your portfolio given its recent upgrade to a Zacks Rank #1 (Strong Buy). This upgrade primarily reflects an upward trend in earnings ...